Table 3 The first-line treatment selection by stage
From: The role of radiotherapy in small cell carcinoma of the esophagus: a retrospective study
First-line treatment | n = 235 | Stage I (n = 27) | Stage II (n = 38) | Stage III (n = 60) | Stage IV (n = 110) |
|---|---|---|---|---|---|
CT | 83 (35.3%) | 0 | 4 (10.5%) | 12 (19.9%) | 67 (60.9%) |
RT | 7 (3.0%) | 0 | 2 (5.2%) | 2 (3.4%) | 3 (2.7%) |
CRT | 52 (22.1%) | 0 | 5 (13.2%) | 20 (33.3%) | 27 (24.5%) |
Surgery | 20 (8.5%) | 8 (29.6%) | 5 (13.2%) | 4 (6.7%) | 3 (2.7%) |
S + CT | 68 (28.9%) | 18 (66.7%) | 21(55.3%) | 21(35.0%) | 8 (7.3%) |
S + RT | 1(0.5%) | 0 | 0 | 1 (1.7%) | 0 |
S + CRT | 4 (1.7%) | 1 (3.7%) | 1 (2.6%) | 0 | 2 (1.8%) |